771 related articles for article (PubMed ID: 30232183)
1. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
[TBL] [Abstract][Full Text] [Related]
2. Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure.
Allweiss L; Testoni B; Yu M; Lucifora J; Ko C; Qu B; Lütgehetmann M; Guo H; Urban S; Fletcher SP; Protzer U; Levrero M; Zoulim F; Dandri M
Gut; 2023 May; 72(5):972-983. PubMed ID: 36707234
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the Termini of Cytoplasmic Hepatitis B Virus Deproteinated Relaxed Circular DNA.
Cai D; Yan R; Xu JZ; Zhang H; Shen S; Mitra B; Marchetti A; Kim ES; Guo H
J Virol; 2020 Dec; 95(1):. PubMed ID: 33055252
[TBL] [Abstract][Full Text] [Related]
4. Untying relaxed circular DNA of hepatitis B virus by polymerase reaction provides a new option for accurate quantification and visualization of covalently closed circular DNA.
Kamiya N; Sugimoto T; Abe-Chayama H; Akiyama R; Tsuboi Y; Mogami A; Imamura M; Hayes CN; Chayama K
J Gen Virol; 2022 Feb; 103(2):. PubMed ID: 35130138
[TBL] [Abstract][Full Text] [Related]
5. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
Sheraz M; Cheng J; Tang L; Chang J; Guo JT
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
[TBL] [Abstract][Full Text] [Related]
6. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.
Tang L; Sheraz M; McGrane M; Chang J; Guo JT
PLoS Pathog; 2019 Apr; 15(4):e1007742. PubMed ID: 31026293
[TBL] [Abstract][Full Text] [Related]
7. A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance.
Tu T; Zehnder B; Qu B; Ni Y; Main N; Allweiss L; Dandri M; Shackel N; George J; Urban S
Antiviral Res; 2020 Sep; 181():104865. PubMed ID: 32726641
[TBL] [Abstract][Full Text] [Related]
8. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
[TBL] [Abstract][Full Text] [Related]
9. Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
Kitamura K; Que L; Shimadu M; Koura M; Ishihara Y; Wakae K; Nakamura T; Watashi K; Wakita T; Muramatsu M
PLoS Pathog; 2018 Jun; 14(6):e1007124. PubMed ID: 29928064
[TBL] [Abstract][Full Text] [Related]
10. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
[TBL] [Abstract][Full Text] [Related]
11. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.
Guo H; Jiang D; Zhou T; Cuconati A; Block TM; Guo JT
J Virol; 2007 Nov; 81(22):12472-84. PubMed ID: 17804499
[TBL] [Abstract][Full Text] [Related]
13. PCR mediated recombination impacts the analysis of hepatitis B Virus covalently closed circular DNA.
Suspène R; Thiers V; Vartanian JP; Wain-Hobson S
Retrovirology; 2016 Dec; 13(1):84. PubMed ID: 27998270
[TBL] [Abstract][Full Text] [Related]
14. A sensitive and accurate quantification method for the detection of hepatitis B virus covalently closed circular DNA by the application of a droplet digital polymerase chain reaction amplification system.
Mu D; Yan L; Tang H; Liao Y
Biotechnol Lett; 2015 Oct; 37(10):2063-73. PubMed ID: 26187315
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus Capsid: The Core in Productive Entry and Covalently Closed Circular DNA Formation.
Mendenhall MA; Hong X; Hu J
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992351
[TBL] [Abstract][Full Text] [Related]
16. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.
Guo JT; Guo H
Antiviral Res; 2015 Oct; 122():91-100. PubMed ID: 26272257
[TBL] [Abstract][Full Text] [Related]
18. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
[TBL] [Abstract][Full Text] [Related]
19. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.
Lutgehetmann M; Volz T; Köpke A; Broja T; Tigges E; Lohse AW; Fuchs E; Murray JM; Petersen J; Dandri M
Hepatology; 2010 Jul; 52(1):16-24. PubMed ID: 20578126
[TBL] [Abstract][Full Text] [Related]
20. [Comparative analysis of drug resistant mutations in the reverse transcriptase domain of hepatitis B virus covalently closed circular DNA and the viral relax circle DNA].
Su HL; Liu YM; Ren XQ; Xu DP; Zhong YW
Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):818-21. PubMed ID: 21138628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]